您的位置: 首页 > 农业专利 > 详情页

GENE THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA USING GENETICALLY CORRECTED AUTOLOGOUS KERATINOCYTES
专利权人:
The Board of Trustees of the Leland Stanford Junior University;U.S. GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
发明人:
Zurab Siprashvili,Ngon T. Nguyen,M. Peter Marinkovich,Jean Tang,Alfred T. Lane,Paul A. Khavari
申请号:
US16066253
公开号:
US20190382724A1
申请日:
2017.01.03
申请国别(地区):
US
年份:
2019
代理人:
摘要:
Methods are provided for the cell-based delivery of collagen VII for the treatment of Epidermolysis Bullosa and corneal erosion. The disclosure also provides a composition and a pharmaceutical composition comprises, comprise, or alternatively consist essentially of, or yet further consist of a keratinocyte sheet or a corneal cell sheet.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充